publication

  • Report On the preparations of the Indian hemp, or Gunjah.

    William Brooke O’Shaughnessy, 1843

  • Observations on the Cannabis Indica, or Indian Hemp. Provincial Medical Journal and Retrospect of the Medical Sciences.

    Ley, W., 1843.

  • Report On The Standardization of preparations of indian hemp. Part I. The value of the “iodine number.”

    Marshall, C.R. & Wigner, J.H., 1911.

  • An essay on Hasheesh.

    Robinson, V., 1912.

  • Report On The Standardization Of Preparations Of Indian Hemp. Part II. The Value Of The “Acetyl number.”

    Marshall, C.R. & Wood, J.K., 1912.

  • Marihuana, America’s New Drug Problem. Nature.

    Todd, A., 1939.

Adams CBD & THC series I – XIII

  • Structure of Cannabidiol, a Product Isolated from the Marihuana Extract of Minnesota Wild Hemp

    Adams, R. et al., 1940.

  • Structure of Cannabidiol. II. Absorption Spectra Compared with those of Various Dihydric Phenols.

    Adams, R., Cain, C.K. & Wolff, H., 1940.

  • Structure of Cannabidiol. III. Reduction and Cleavage.

    Adams, R., Hunt, M. & Clark, J.H., 1940.

  • Structure of Cannabidiol. IV. The position of the linkage between the two rings.

    Adams, R. et al., 1940.

  • Structure of Cannabidiol. V. Position of the alicyclic double bonds.

    Adams, R. et al., 1940.

  • Structure of Cannabidiol. VI. Isomerization of Cannabidiol to Tetrahydrocannabinol, a Physiologically Active Product. Conversion of Cannabidiol to Cannabinol1.

    Adams, R. et al., 1940.

  • Structure of Cannabidiol. VII. A Method of Synthesis of a Tetrahydrocannabinol which Possesses Marihuana Activity.

    Adams, R. & Baker, B.R., 1940.

  • Structure of Cannabidiol. VIII. Position of the double bonds in cannabidiol. Marihuana activity of tetrahydrocannabinols.

    Adams, R. et al., 1940.

  • Tetrahydrocannabinol Homologs with Marihuana Activity. IX.

    Adams, R. et al., 1941.

  • Tetrahydrocannabinol Homologs and Analogs with Marihuana Activity. X.

    Adams, R., Smith, C.M. & Loewe, S., 1941.

  • Tetrahydrocannabinol Analogs with Marihuana Activity. XI.

    Adams, R., Cain, C.K. & Loewe, S., 1941.

  • Structure of Cannabidiol. XII. Isomerization to Tetrahydrocannabinols.

    Adams, R. et al., 1941.

  • Tetrahydrocannabinol Homologs and Analogs with Marihuana Activity. XIII.

    Adams, R. et al., 1942.

Adams Cannabinol Series I – V

  • Report On the preparations of the Indian hemp, or Gunjah.

    William Brooke O’Shaughnessy, 1843

  • Observations on the Cannabis Indica, or Indian Hemp. Provincial Medical Journal and Retrospect of the Medical Sciences.

    Ley, W., 1843.

  • Report On The Standardization of preparations of indian hemp. Part I. The value of the “iodine number.”

    Marshall, C.R. & Wigner, J.H., 1911.

  • An essay on Hasheesh.

    Robinson, V., 1912.

  • Report On The Standardization Of Preparations Of Indian Hemp. Part II. The Value Of The “Acetyl number.”

    Marshall, C.R. & Wood, J.K., 1912.

Adams, Todd & Others

  • A Physiologically Active Principle from Cannabis sativa (Marihuana).

    Haagen-Smit, A.J. et al., 1940.

  • Cannabidiol and cannabol: constituents of cannabis sativa.

    Jacob A & Todd, A., 1940.

  • Chemistry of hemp drugs.

    Todd, A., 1940.

  • Conversion of a cannabidiol to a product with marihuana activity. A type reaction for synthesis of analogous substances. Conversion of cannabidiol to cannabinol.

    Adams, R. et al., 1940.

  • Isolation of Cannabinol, Cannabidiol and Quebrachitol from Red Oil of Minnesota Wild Hemp.

    Adams, R., Pease, D.C. & Clark, J.H., 1940.

  • Marihuana.

    Adams, R., 1940.

  • Synthesis of cannabinol.

    Powell, G. & Bremby, T.H., 1940.

Note: This material is not for mass disclosure but intended only for the interest or benefit of students and colleagues.

  • Hashish—I The structure of cannabidiol Tetrahedron.

  • Concerning the Isomerization of Delta-1(6)-Tetrahydrocannabinol.

    Gaoni, Y. & Mechoulam, R., 1966.

  • Stereospecific synthesis of (-)-. DELTA. 1-and (-)-. DELTA. 1 (6)-tetrahydrocannabinols

    Mechoulam, R., Braun, P. & Gaoni, Y., 1967.

  • Stereospecifically Labeled Delta-1-6-Tetrahydrocannabinol.

    Burstein, S. & Mechoulam, R., 1968.

  • Stereoelectronic Factor in the Chloranil Dehydrogenation of Cannabinoids. Total Synthesis of dl-Cannabichromene.

    Mechoulam, R., Yagnitinsky, B. & Gaoni, Y., 1968.

  • A new tetrahydrocannabinolic acid.

    Mechoulam, R. et al., 1969.

  • Concerning the Isomerization of Delta-1(6)-Tetrahydrocannabinol.

    Gaoni, Y. & Mechoulam, R., 1966.

  • Stereospecific synthesis of (-)-. DELTA. 1-and (-)-. DELTA. 1 (6)-tetrahydrocannabinols

    Mechoulam, R., Braun, P. & Gaoni, Y., 1967.

  • Stereospecifically Labeled Delta-1-6-Tetrahydrocannabinol.

    Burstein, S. & Mechoulam, R., 1968.

  • Stereoelectronic Factor in the Chloranil Dehydrogenation of Cannabinoids. Total Synthesis of dl-Cannabichromene.

    Mechoulam, R., Yagnitinsky, B. & Gaoni, Y., 1968.

  • A new tetrahydrocannabinolic acid.

    Mechoulam, R. et al., 1969.

  • Isolation, structure, and partial synthesis of an active constituent of hashish.

    Gaoni, Y. & Mechoulam, R., 1964.

  • A Total Synthesis of Dl-Delta-1-Tetrahydrocannabinol, the Active Constituent of Hashish.

    Mechoulam, R. & Gaoni, Y., 1965.

  • Hashish—IV. The Isolation and Structure of cannabinolic cannabidiolic and cannabigerolic acids.

    Mechoulam, R. & Gaoni, Y., 1965.

  • Active constituents of hashish. Synthesis of dl-delta-6-3,4-trans-tetrahydrocannabinol.

    Taylor, C.T., Lenard, K. & Shvo, Y., 1965.

  • Concerning the Isomerization of Delta-1(6)-Tetrahydrocannabinol.

    Gaoni, Y. & Mechoulam, R., 1966.

  • Stereospecific synthesis of (-)-. DELTA. 1-and (-)-. DELTA. 1 (6)-tetrahydrocannabinols

    Mechoulam, R., Braun, P. & Gaoni, Y., 1967.

  • Stereospecifically Labeled Delta-1-6-Tetrahydrocannabinol.

    Burstein, S. & Mechoulam, R., 1968.

  • Stereoelectronic Factor in the Chloranil Dehydrogenation of Cannabinoids. Total Synthesis of dl-Cannabichromene.

    Mechoulam, R., Yagnitinsky, B. & Gaoni, Y., 1968.

  • A new tetrahydrocannabinolic acid.

    Mechoulam, R. et al., 1969.

  • The Lennox-Gastaut syndrome.

    Beaumanoir, A., & Blume, W., 2005.

  • The prevalence and demographic distribution of treated epilepsy.

    D’Souza, W. J., Quinn et al, 2012.

  • Mechanisms of epileptogenesis: A convergence on neural circuit dysfunction.

    Goldberg, E. M., & Coulter, D. A., 2013.

  • Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies.

    Kwan, P., Arzimanoglou, et al. 2010.

  • Understanding the basic mechanisms underlying seizures in mesial temporal lobe epilepsy and possible therapeutic targets: a review.

    O’Dell, C. M., Das, A., Wallace et al. 2012.

The endocannabinoid system and epileptogenesis

  • The endocannabinoid system controls key epileptogenic circuits in the hippocampus.

    Monory, K., Massa, F., Egertová et al. 2006.

  • Dynamic changes of CB1 receptor expression in hippocampi of epileptic mice and humans.

    Maglóczky, Z., Tóth, K. et al. 2010.

  • Molecular Composition of the Endocannabinoid System at Glutamatergic Synapses.

    Katona, I., Urbán et al. 2006.

Cannabinoids and Epilepsy

  • Agonistic Properties of Cannabidiol at 5-HT1a Receptors.

    Russo, E., Burnett, A., Hall, B., & Parker, K., 2005.

  • Are cannabidiol and Δ9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review.

    McPartland, J. M., Duncan, M., Di Marzo, V., & Pertwee, R. G., 2015.

  • Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures.

    Jones, N. A., Glyn, S. E., Akiyama et al., 2012.

  • Cannabinoids for epilepsy.

    Gloss, D. and Vickrey, B., 2014.

  • The case for medical marijuana in epilepsy.

    Maa, E. and Figi, P., 2014.

  • Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.

    Devinsky, O., Cilio, M.R., Cross, et al., 2014.

  • Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial.

    Devinsky, O., Marsh, E., Friedman, D. et al, 2016.

  • Epilepsy and Cannabinoids: A Literature Review.

    UTT BioPharma, 2016.

  • THCA and THCV molecules with great therapeutic potential Literature Review.

  • Cannabinol: degradation leads to opportunity?

  • Public Submission made to the Regulator of Medicinal Cannabis Bill 2014.

  • Treating Chronic Pain with Cannabis-Derived Compounds.

  • Submission to the Victorian Law Review Commission (VLRC).

  • Epilepsy and Cannabinoids: A Literature Review.

  • Cannabis effects and therapeutic cues: The “Munchies”